Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

TH2-polarized CD4+ T cells and macrophages limit efficacy of radiation therapy.

Shiao SL, Ruffell B, DeNardo D, Faddegon B, Park CC, Coussens LM.

Cancer Immunol Res. 2015 Feb 25. pii: canimm.0232.2014. [Epub ahead of print]

PMID:
25716473
[PubMed - as supplied by publisher]
2.

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho CM, Pryer N, Daniel D, Hwang ES, Rugo HS, Coussens LM.

Cancer Cell. 2014 Nov 10;26(5):623-37. doi: 10.1016/j.ccell.2014.09.006. Epub 2014 Oct 16.

PMID:
25446896
[PubMed - indexed for MEDLINE]
3.

Duality of the immune response in cancer: lessons learned from skin.

Medler TR, Coussens LM.

J Invest Dermatol. 2014 Oct 10;134(e1):E23-8. doi: 10.1038/skinbio.2014.5. Review. No abstract available.

PMID:
25302470
[PubMed - indexed for MEDLINE]
4.

Manipulating microRNAs to regulate macrophage polarization in gliomas.

Anand S, Coussens LM.

J Natl Cancer Inst. 2014 Aug 18;106(8). pii: dju230. doi: 10.1093/jnci/dju230. Print 2014 Aug. No abstract available.

PMID:
25136034
[PubMed - indexed for MEDLINE]
5.

Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Fornetti J, Martinson HA, Betts CB, Lyons TR, Jindal S, Guo Q, Coussens LM, Borges VF, Schedin P.

J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):213-28. doi: 10.1007/s10911-014-9322-z. Epub 2014 Jun 22.

PMID:
24952477
[PubMed - in process]
6.

B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.

Affara NI, Ruffell B, Medler TR, Gunderson AJ, Johansson M, Bornstein S, Bergsland E, Steinhoff M, Li Y, Gong Q, Ma Y, Wiesen JF, Wong MH, Kulesz-Martin M, Irving B, Coussens LM.

Cancer Cell. 2014 Jun 16;25(6):809-21. doi: 10.1016/j.ccr.2014.04.026. Epub 2014 Jun 5.

PMID:
24909985
[PubMed - indexed for MEDLINE]
7.

A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.

Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG, Dubensky TW Jr, Hassan R, Armstrong TD, Jaffee EM.

Gastroenterology. 2014 Jun;146(7):1784-94.e6. doi: 10.1053/j.gastro.2014.02.055. Epub 2014 Mar 6.

PMID:
24607504
[PubMed - indexed for MEDLINE]
8.

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells.

Strachan DC, Ruffell B, Oei Y, Bissell MJ, Coussens LM, Pryer N, Daniel D.

Oncoimmunology. 2013 Dec 1;2(12):e26968. Epub 2013 Dec 4.

PMID:
24498562
[PubMed]
Free PMC Article
9.

Poker face no more: cancer recurrence reveals its hand.

Chan CJ, Coussens LM.

Nat Med. 2013 Dec;19(12):1569-70. doi: 10.1038/nm.3410. No abstract available.

PMID:
24309652
[PubMed - indexed for MEDLINE]
10.

Dendritic cells, inflammation, and breast cancer.

Palucka K, Coussens LM, O'Shaughnessy J.

Cancer J. 2013 Nov-Dec;19(6):511-6. doi: 10.1097/PPO.0000000000000007. Review.

PMID:
24270350
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cathepsin C is a tissue-specific regulator of squamous carcinogenesis.

Ruffell B, Affara NI, Cottone L, Junankar S, Johansson M, DeNardo DG, Korets L, Reinheckel T, Sloane BF, Bogyo M, Coussens LM.

Genes Dev. 2013 Oct 1;27(19):2086-98. doi: 10.1101/gad.224899.113. Epub 2013 Sep 24.

PMID:
24065739
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.

Ganesan AP, Johansson M, Ruffell B, Yagui-Beltrán A, Lau J, Jablons DM, Coussens LM.

J Immunol. 2013 Aug 15;191(4):2009-17. doi: 10.4049/jimmunol.1301317. Epub 2013 Jul 12. Erratum in: J Immunol. 2013 Nov 15;191(10):5319. Beltran, Adam [corrected to Yagui-Beltrán, Adam].

PMID:
23851682
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Some DCs are "B"etter.

Ruffell B, Coussens LM.

Immunity. 2013 Apr 18;38(4):626-8. doi: 10.1016/j.immuni.2013.03.011.

PMID:
23601679
[PubMed]
Free Article
14.

B cells and their mediators as targets for therapy in solid tumors.

Gunderson AJ, Coussens LM.

Exp Cell Res. 2013 Jul 1;319(11):1644-9. doi: 10.1016/j.yexcr.2013.03.005. Epub 2013 Mar 13. Review.

PMID:
23499742
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Coussens LM, Zitvogel L, Palucka AK.

Science. 2013 Jan 18;339(6117):286-91. doi: 10.1126/science.1232227. Review. Erratum in: Science. 2013 Mar 29;339(6127):1522.

PMID:
23329041
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MR imaging of tumor-associated macrophages.

Daldrup-Link H, Coussens LM.

Oncoimmunology. 2012 Jul 1;1(4):507-509.

PMID:
22754769
[PubMed]
Free PMC Article
17.

Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Hanahan D, Coussens LM.

Cancer Cell. 2012 Mar 20;21(3):309-22. doi: 10.1016/j.ccr.2012.02.022. Review.

PMID:
22439926
[PubMed - indexed for MEDLINE]
Free Article
18.

Tumor microenvironment complexity: emerging roles in cancer therapy.

Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, DeClerck YA.

Cancer Res. 2012 May 15;72(10):2473-80. doi: 10.1158/0008-5472.CAN-12-0122. Epub 2012 Mar 13.

PMID:
22414581
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Differential macrophage programming in the tumor microenvironment.

Ruffell B, Affara NI, Coussens LM.

Trends Immunol. 2012 Mar;33(3):119-26. doi: 10.1016/j.it.2011.12.001. Epub 2012 Jan 23. Review.

PMID:
22277903
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immune microenvironments in solid tumors: new targets for therapy.

Shiao SL, Ganesan AP, Rugo HS, Coussens LM.

Genes Dev. 2011 Dec 15;25(24):2559-72. doi: 10.1101/gad.169029.111. Review.

PMID:
22190457
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk